Effects of Upper Extremity Aerobic Exercise Training in Hematopoietic Stem Cell Transplantation Recipients
1 other identifier
interventional
30
1 country
1
Brief Summary
Hematologic malignancy is a tumor of myeloid or lymphatic cells that affects lymph nodes with the involvement of blood, bone marrow or other organs.There are various treatment options for hematological malignancies ranging from follow-up to single or multiple agent chemotherapy, radiotherapy, immunotherapy and autologous or allogeneic hematopoietic stem cell transplantations (HSCT). The general recommendation for patients is to relax and avoid intense exercise, regardless of the devastating consequences of neglecting physical exercise. Patients also go to relaxation by reducing their activity to avoid fatigue, which leads to loss of muscle strength and endurance. As a consequence of all, fatigue, vomiting, weight loss, anemia, depression, decreased aerobic capacity, muscle weakness, decreased physical function and poor quality of life are observed in HSCT recipients. It has been shown that physical exercises improve oxygen consumption, depression and fatigue, cardiorespiratory fitness, muscle strength and physical well-being in patients with hematologic malignancies who are at stages of various treatments. In literature, effects of upper extremity aerobic exercise training have been investigated in patients with spinal cord injury, neuromuscular diseases, claudication, hypertension, multiple sclerosis, heart failure, paraplegic patients and healthy individuals. Results of these studies has shown that upper extremity aerobic exercise training improves walking distance, increases oxygen pulse, muscle strength and endurance of upper extremity. No study was observed to investigate the effects of upper extremity aerobic exercise training on exercise capacity and quality of life in HSCT recipients, as we know. For this reason, our aim is to investigate the effects of upper extremity aerobic exercise training on exercise capacity and quality of life in HSCT recipients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 16, 2016
CompletedFirst Posted
Study publicly available on registry
January 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFebruary 25, 2021
February 1, 2021
2.3 years
December 16, 2016
February 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
functional exercise capacity evaluation
Evaluated with 6-minute walking test
6-week
Secondary Outcomes (9)
pulmonary functions test
6-week
muscle strength
6-week
cough strength
6-week
physical activity level
6-week
fatigue severity
6-week
- +4 more secondary outcomes
Study Arms (2)
Treatment group: aerobic exercise
EXPERIMENTALThe upper extremity aerobic exercise training with an arm ergometer will be performed in the treatment group so that training intensity will be between 60% and 80% of the maximum heart rate, dyspnea perception will be 3-4 according to Modified Borg Scale and fatigue perception will be 5-6 according to Modified Borg Scale, training duration will be a 6-week.
Control group: deep breathing exercise
NO INTERVENTIONDeep breathing exercises combinated with arm movements will be given as a home schedule in the control group. Training duration will be a 6-week.
Interventions
Range of maximal heart rate is being followed by a polar band during supervised session each week. Aerobic exercise is being trained for 30 min-per/day, 3 days/week, 6 weeks. All sessions are being performed by a physiotherapist at cardiopulmonary rehabilitation department.
Eligibility Criteria
You may qualify if:
- being an hematopoietic stem cell transplantation recipient during the intermediate/late post-transplant phase (\>100 days),
- years of age
- under standard medications.
You may not qualify if:
- having a cognitive disorder,
- orthopedic or neurological disease with a potential to affect functional capacity,
- comorbidities such as asthma, chronic obstructive pulmonary disease (COPD), acute infections or pneumonia,
- problems which may prevent training such as visual problems and mucositis
- having metastasis to any region (bone etc.)
- having acute hemorrhage in the intracranial and / or lung and other areas
- having any contraindication to exercise training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation
Ankara, Turkey (Türkiye)
Related Links
- 'Best supportive care' has had its day.
- Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
- Aerobic physical exercise for adult patients with haematological malignancies.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gülşah Barğı, MSc.
Gazi University
- STUDY DIRECTOR
Meral Boşnak Güçlü, PhD.
Gazi University
- PRINCIPAL INVESTIGATOR
Zübeyde Nur Özkurt, PhD.
Gazi University
- PRINCIPAL INVESTIGATOR
Münci Yağcı, PhD.
Gazi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
December 16, 2016
First Posted
January 2, 2017
Study Start
April 1, 2016
Primary Completion
August 1, 2018
Study Completion
September 1, 2018
Last Updated
February 25, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared.